1. Home
  2. KXIN vs CERO Comparison

KXIN vs CERO Comparison

Compare KXIN & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KXIN
  • CERO
  • Stock Information
  • Founded
  • KXIN 2015
  • CERO 2017
  • Country
  • KXIN China
  • CERO United States
  • Employees
  • KXIN N/A
  • CERO N/A
  • Industry
  • KXIN Retail-Auto Dealers and Gas Stations
  • CERO
  • Sector
  • KXIN Consumer Discretionary
  • CERO
  • Exchange
  • KXIN Nasdaq
  • CERO Nasdaq
  • Market Cap
  • KXIN 9.4M
  • CERO 9.6M
  • IPO Year
  • KXIN N/A
  • CERO N/A
  • Fundamental
  • Price
  • KXIN $0.65
  • CERO $7.63
  • Analyst Decision
  • KXIN
  • CERO Strong Buy
  • Analyst Count
  • KXIN 0
  • CERO 2
  • Target Price
  • KXIN N/A
  • CERO $45.00
  • AVG Volume (30 Days)
  • KXIN 210.5K
  • CERO 27.4K
  • Earning Date
  • KXIN 01-01-0001
  • CERO 08-22-2025
  • Dividend Yield
  • KXIN N/A
  • CERO N/A
  • EPS Growth
  • KXIN N/A
  • CERO N/A
  • EPS
  • KXIN N/A
  • CERO N/A
  • Revenue
  • KXIN N/A
  • CERO N/A
  • Revenue This Year
  • KXIN N/A
  • CERO N/A
  • Revenue Next Year
  • KXIN N/A
  • CERO N/A
  • P/E Ratio
  • KXIN N/A
  • CERO N/A
  • Revenue Growth
  • KXIN N/A
  • CERO N/A
  • 52 Week Low
  • KXIN $0.64
  • CERO $6.71
  • 52 Week High
  • KXIN $29.54
  • CERO $895.40
  • Technical
  • Relative Strength Index (RSI)
  • KXIN 35.67
  • CERO 42.73
  • Support Level
  • KXIN $0.68
  • CERO $8.07
  • Resistance Level
  • KXIN $0.74
  • CERO $8.00
  • Average True Range (ATR)
  • KXIN 0.07
  • CERO 0.38
  • MACD
  • KXIN -0.01
  • CERO -0.01
  • Stochastic Oscillator
  • KXIN 2.90
  • CERO 2.73

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

Share on Social Networks: